Introduction
Coronary artery disease remains highly prevalent in contemporary society and over 1000000 revascularisation procedures by percutaneous coronary intervention (PCI) are performed annually worldwide. PCI has seen significant improvement in clinical outcomes with the current generation of drug eluting stents. The role of PCI in multivessel coronary disease has been expanded with current trial evidence indicating equipoise between PCI and coronary artery by-pass surgery in selected groups.
Increasingly, coronary artery by-pass surgery (CABG) or PCI is being considered as an equivalent revascularisation strategy within the same patient population. Given the options available to clinicians and patients it is important to have robust tools to accurately compare the risk and benefits of selected strategies when making management decisions. Whilst these tools have been available to the cardiac surgeons for some time (Granton & Cheng, 2008) , an equivalent tool for the interventional cardiologist has only recently been published.
The CANADA Score is a risk prediction model for determining 30 day mortality risk in patients undergoing elective, urgent and emergent PCI. Its development and validation will be discussed with reference to the established cardiac surgical risk calculators currently available.
Risk prediction models
Risk prediction models are statistical models produced from patient databases using a combination of individual risk predication markers and are used by clinicians and patients for making treatment decisions. Model inaccuracy and ineffectiveness can therefore have negative implications on risk measurement and subsequent patient decisions and outcomes. The accuracy of the model is typically summarised in terms of the model's discrimination and calibration (Janes et al, 2008) . The applicability of a risk model to a patient population is determined by validation.
Discrimination
Discrimination is the ability of the model to correctly classify outcomes (Nathanson & Higgins, 2008) . The statistical measures of area under the curve (AUC) or concordance index (C-index) are commonly used to describe how well patients are classified within the model.
Patients typically are assigned a positive classification if the model predicts the probability of an outcome as >0.5. Conversely, a negative classification indicates the model predicts the probability of an outcome is <0.5. A patient is therefore correctly classified when an outcome event occurs in a patient with a positive classification, or when no event occurs in a patient with a negative classification. Sensitivity and specificity are derived from the fraction of correctly classified patients. The receiver operating characteristic (ROC) curve is derived from the plot of specificity against (1 -sensitivity), and the area under the ROC curve (AUC) measures the discriminatory ability of the model. An AUC of 0.5 indicates no discriminatory ability and 1.0 indicates perfect discrimination (Cook, 2008) . A good model would have AUC 0.7 -0.9.
Calibration
Calibration is determined by comparing the predicted and observed outcomes within subgroups of increasing risk within the dataset and applying the Hosmer-Lemeshow (H-L) statistical test (Hosmer & Lemeshow, 2000) to assess "goodness of fit". The H-L goodness of fit test divides subjects into deciles based on predicted probabilities and calculates a chisquare from observed and expected frequencies. If the H-L statistic has p-value >0.05, it implies there is no significant difference between observed and model-predicted values and therefore the model is well calibrated. Calibration plots can be used to give a graphical representation of model calibration.
Validation
Strategies to validate statistical models include (Altman & Royston, 2000) : a. Internal -evaluation from a single dataset
Internal validation refers to the application of a model to the same cohort from which it was derived, often by splitting one dataset into separate training and validation cohorts. This can be problematic as models tend to over fit the data and calibration appears erroneously good (Vickers & Cronin, 2010 (Shroyer et al, 2003) .
EuroSCORE
A European multi-national database was established in 1995 (Nashef et al, 1999) and information on risk factors and mortality was collected for 19 030 consecutive adult patients undergoing cardiac surgery under cardiopulmonary bypass in 128 surgical centres in eight European states . Data were collected for 68 preoperative and 29 operative risk factors proven or believed to influence mortality. From this a series of objective risk factors (Table 1) were weighted by regression analysis and developed into an additive score (additive EuroSCORE) to predict mortality. Overall, 14 799 patients were divided into a developmental cohort (n= 13 302) and validation cohort (n= 1479). The 30 day mortality was for the entire cohort was 4.7%. The additive EuroSCORE had good discrimination in both the development (c-index 0.79) and validation (c-index 0.76) cohort, as well as good calibration (H-L p value <0.40 & <0.68 respectively) ( Table 2 ). The additive EuroSCORE was further externally validated in a North American population. Despite demographic differences the model performed well with discriminatory c-index 0.75 and excellent calibration (predicted and observed mortality 4.15%) (Nashef et al, 2002) .
A limitation of the additive EuroSCORE was underestimation of risk in very high risk populations (Sergeant et al, 2001 ). A second model was published using the coefficient of the variables in the logistic regression data rather than additive weights to predict mortality. The logistic EuroSCORE had similar discrimination (c-index 0.785) to the additive model but superior accuracy in high risk populations. The models diverged at a predicted mortality of 
PCI models
Early models examining risk associated with percutaneous coronary interventions were well validated for the predication of in-hospital mortality ( Moscucci et al, 2001; Qureshi et al, 2003; Resnic et al, 2001; Shaw et al, 2002; Singh et al, 2002; Wu et al, 2006) . However, these models had the potential to miss adverse events due to the nature of contemporary PCI where many patients are discharged within 24 hours of admission. As patients may be suitable for revascularization by either CABG or PCI it was important to develop a tool to facilitate an appropriate comparison of outcomes between these strategies.
NCDR CathPCI risk score
Contemporary risk scores were developed from the National Cardiovascular Data Registry (NCDR) (Peterson et al, 2010) . The NCDR CathPCI Registry catalogues patient characteristics, angiographic and procedural details and in-hospital outcomes. From this, various risk models to predict in-hospital mortality were derived from pre-procedural and procedural data (full model), as well as a simplified model based on pre-procedure data only. To establish 30-day mortality, the NCDR records for patients aged over 65 were linked to claims data from the national Centers for Medicare and Medicaid Services (CMS). Linked data from 204111 patients observed in-hospital mortality as 1.99% and 30 day mortality as 2.94%. The c-index for predicating 30-day mortality using the NCDR in-patient mortality model was 0.86.
The CANADA score
The British Columbia Cardiac Registry (BCCR) is a population based database for all invasive cardiac procedures performed in British Columbia, Canada. The registry is used for clinical, administrative and research purposes. The linkage of BCCR data with the death registry of the British Columbia (BC) Vital statistics Agency facilitates outcome research. All procedures were performed at four academic tertiary centres that collectively perform 7500 PCI annually.
All patients who had PCI performed in British Columbia (BC) from 2000 -2005 who were BC residents were included in the study (Hamburger et al, 2009 ). PCI was defined as any coronary artery procedure that included balloon angioplasty, stent implantation, atherectomy, brachytherapy and thrombectomy. Second or subsequent PCI were not included for further analysis. All cause mortality data was obtained from the BC Vital Statistics Agency.
The study cohort was divided into two groups. Procedures between January 01, 2000 and December 31, 2004 formed the training set that was used to develop the multivariable predictive model for all-cause 30-day mortality. Procedures from 2005 were used to validate the model.
Variables for predicting 30-day mortality post PCI included patient demographics, comorbidities and clinical features such as indication for procedure and disease anatomy.
Variables that were significantly associated with 30-day mortality in the univariate analysis (Table 3) or that were considered to be clinically important predictors for 30-day mortality were assessed in a stepwise logistic regression analysis. Only significant predictors (P < 0.05) in the multiple logistic regression analysis were kept in the final predictive model (Table 4) .
A total of 32 899 procedures were performed. These were divided into 26 350 in the training set and 6549 in the validation set. The overall 30-day mortality was 1.5% (n=500), with mortality in the training set 1.5% (n=406) and validation set 1.4% (n=94) 
Comparison of risks -Surgical versus percutaneous revascularisation
Increasingly it has become relevant to select the optimal revascularization strategy for patients deemed appropriate for revascularisation by either coronary artery bypass grafting or percutaneous intervention. Published studies of coronary anatomy alone have shown to predict the need for future revascularisation (Serruys et al, 2009; Sianos et al, 2005) , but not mortality. The scores derived from an anatomical assessment alone has been shown to have only modest correlation to predicted risk using either surgical (logistic EuroSCORE) or percutaneous (CANADA Score) risk calculators that incorporate clinical and anatomical factors (Hoole & Hamburger, 2011) . The same study found comparative risk assessment using either logistic EuroSCORE or CANADA Score has good correlation (R=0.80) and importantly recognised that patients with high predicted risk for surgery may have higher risk for a percutaneous revascularisation strategy (Figure 4 ). This implies patients declined for surgery should not necessarily default to a PCI treatment strategy. It must be noted that the definition of risk factors in different models may vary and must be considered when applying multiple models to individual patients (Table 5) . 
Conclusion
Predicting procedural risk enables the correct treatment decisions to be made and allows valid informed consent and accurate patient counselling. This is particularly important as PCI has become accepted as a viable alternative to established surgical intervention. Early assessment of risk with PCI was limited to short term events that ignored important late events and prevented direct comparison with surgical risk predication tools. The CANADA Score was developed to accurately predict 30 day mortality risk and has been externally validated in large North American cohorts demonstrating broad applicability to varied patient groups. The CANADA Score confirms that both anatomical and clinical data are required to provide accurate and discriminatory 30 day mortality risk prediction and it therefore allows comparison with well validated surgical risk prediction models to guide optimal revascularisation strategy. Application of the CANADA Score to patients with high surgical risk demonstrates the potential for equal or greater risk with a percutaneous strategy and challenges the traditional notion that percutaneous revascularization should be a default strategy for these patients. The CANADA Score is available as an on-line calculator (www.canadascore.org) ( Figure 5 ) facilitating easy integration into regular clinical practice. 
